Apogenix develops innovative immunotherapeutics for the treatment of cancer and viral infections, such as COVID-19. Based on a proprietary technology platform, the company has developed the drug candidate asunercept that inhibits the CD95-ligand. Blocking CD95L has a strong scientific rationale to potentially treat various diseases like cancer, ophthalmology- and dermatology-indications and thus asunercept is a pipeline-in-a-drug. 

Apogenix maintains excellent relationships with renowned academic institutions conducting research in the fields of cancer and malignant diseases and is part of an extensive international scientific and medical network.


Job Postings

Sorry, we do not have any vacancies at the moment.


The work environment at Apogenix is characterized by an open, communicative atmosphere with numerous opportunities for personal growth and development. Employees benefit from a high level of independence and responsibility, as well as performance-based salaries.

Should you be interested in a diverse and challenging position in a dynamic work environment, we look forward to receiving your application.

E-Mail: This email address is being protected from spambots. You need JavaScript enabled to view it.